...
首页> 外文期刊>The Journal of Experomental Medicine >I-E+ nonobese diabetic mice develop insulitis and diabetes.
【24h】

I-E+ nonobese diabetic mice develop insulitis and diabetes.

机译:I-E +非肥胖型糖尿病小鼠会患上胰岛炎和糖尿病。

获取原文
           

摘要

The development of type I diabetes in the nonobese diabetic (NOD) mouse is under the control of multiple genes, one or more of which is linked to the major histocompatibility complex (MHC). The MHC class II region has been implicated in disease development, with expression of an I-E transgene in NOD mice shown to provide protection from insulitis and diabetes. To examine the effect of expressing an I-E+ or I-E- non-NOD MHC on the NOD background, three I-E+ and three I-E- NOD MHC congenic strains (NOD.H-2i5, NOD.H-2k, and NOD.H-2h2, and NOD.H-2h4, NOD.H-2i7, and NOD.H-2b, respectively) were developed. Of these strains, both I-E+ NOD.H-2h2 and I-E- NOD.H-2h4 mice developed insulitis, but not diabetes. The remaining four congenic strains were free of insulitis and diabetes. These results indicate that in the absence of the NOD MHC, diabetes fails to develop. Each NOD MHC congenic strain was crossed with the NOD strain to produce I-E+ and I-E- F1 mice; these mice thus expressed one dose of the NOD MHC and one dose of a non-NOD MHC on the NOD background. While a single dose of a non-NOD MHC provided a large degree of disease protection to all of the F1 strains, a proportion of I-E+ and I-E- F1 mice aged 5-12 mo developed insulitis and cyclophosphamide-induced diabetes. When I-E+ F1 mice were aged 9-17 mo, spontaneous diabetes developed as well. These data are the first to demonstrate that I-E+ NOD mice develop diabetes, indicating that expression of I-E in NOD mice is not in itself sufficient to prevent insulitis or diabetes. In fact, I-E- F1 strains were no more protected from diabetes than I-E+ F1 strains, suggesting that other non-NOD MHC-linked genes are important in protection from disease. Finally, transfer of NOD bone marrow into irradiated I-E+ F1 recipients resulted in high incidences of diabetes, indicating that expression of non-NOD MHC products in the thymus, in the absence of expression in bone marrow-derived cells, is not sufficient to provide protection from diabetes.
机译:非肥胖糖尿病(NOD)小鼠中I型糖尿病的发生在多个基因的控制下,其中一个或多个与主要组织相容性复合体(MHC)相关。 MHC II类区域与疾病发展有关,在NOD小鼠中I-E转基因的表达可提供保护,使其免受胰岛素炎和糖尿病的侵害。为了检查在NOD背景上表达I-E +或IE-non-NOD MHC的效果,我们选择了三个I-E +和三个IE-NOD MHC同系菌株(NOD.H-2i5,NOD.H-2k和NOD。分别开发了H-2h2和NOD.H-2h4,NOD.H-2i7和NOD.H-2b。在这些毒株中,I-E + NOD.H-2h2和I-E-NOD.H-2h4小鼠均患上了胰岛炎,但没有糖尿病。其余的四个同系菌株均无胰岛炎和糖尿病。这些结果表明,在没有NOD MHC的情况下,糖尿病无法发展。将每个NOD MHC同基因菌株与NOD菌株杂交,以产生I-E +和I-E-F1小鼠;这些小鼠因此在NOD背景上表达了一剂NOD MHC和一剂非NOD MHC。虽然单剂量的非NOD MHC可以为所有F1菌株提供很大程度的疾病保护,但一部分5至12个月的I-E +和I-E- F1小鼠会出现胰岛炎和环磷酰胺诱发的糖尿病。当I-E + F1小鼠的年龄为9-17 mo时,也会发生自发性糖尿病。这些数据首次证明I-E + NOD小鼠患上了糖尿病,这表明NOD小鼠中I-E的表达本身不足以预防胰岛炎或糖尿病。实际上,与I-E + F1株相比,I-E- F1株没有受到更多的糖尿病保护,这表明其他非NOD MHC连接的基因在预防疾病中很重要。最后,将NOD骨髓转移到受辐照的I-E + F1受体中会导致糖尿病的高发,这表明在胸腺中不含NOD MHC产物的表达,而在骨髓衍生细胞中却没有表达,不足以提供免受糖尿病的保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号